Table 1.
Gene sets enriched in poor outcome | FDR |
---|---|
Boston data | |
Hypoxia and p53 in the cardiovascular system | <0.001 |
Aminoacyl tRNA biosynthesis | <0.001 |
Insulin upregulated genes | <0.001 |
tRNA synthetases | <0.001 |
Leucine deprivation down-regulated genes | <0.001 |
Telomerase up-regulated genes | <0.001 |
Glutamine deprivation down-regulated genes | <0.001 |
Cell cycle checkpoint | <0.001 |
Michigan data | |
Glycolysis gluconeogenesis | <0.001 |
vegf pathway | <0.001 |
Insulin up-regulated genes | <0.001 |
Insulin signaling | 0.021 |
Telomerase up-regulated genes | <0.001 |
Glutamate metabolism | 0.018 |
Ceramide pathway | 0.076 |
p53 signalling | <0.001 |
tRNA synthetases | <0.001 |
Breast cancer estrogen signalling | <0.001 |
Aminoacyl tRNA biosynthesis | <0.001 |
Gene sets identified by Subramanian, Tamayo et al. [8] for Boston and Michigan data are listed with the false discovery rates (FDRs) calculated by our proposed concordant integrative gene set enrichment analysis. Based on the gene set enrichment analysis (GSEA) for each individual data set, the FDRs calculated by Subramanian, Tamayo et al. [8] were between 0.006 to 0.25 (most of them were between 0.1 to 0.2).